stocktwits
Why Is KPTI Stock Down 69% After-Hours Today?
Shares of Karyopharm Therapeutics (KPTI) fell 69% in after-hours trading on Thursday after the biotech company reported that its drug selinexor failed to delay disease progression meaningfully in endometrial cancer in a late-stage clinical trial.What Did The Trial Show?The late-stage study tested s…